Francis V. Chisari

58.5k total citations · 19 hit papers
301 papers, 44.4k citations indexed

About

Francis V. Chisari is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Francis V. Chisari has authored 301 papers receiving a total of 44.4k indexed citations (citations by other indexed papers that have themselves been cited), including 228 papers in Epidemiology, 162 papers in Hepatology and 107 papers in Immunology. Recurrent topics in Francis V. Chisari's work include Hepatitis B Virus Studies (204 papers), Hepatitis C virus research (136 papers) and Immunotherapy and Immune Responses (77 papers). Francis V. Chisari is often cited by papers focused on Hepatitis B Virus Studies (204 papers), Hepatitis C virus research (136 papers) and Immunotherapy and Immune Responses (77 papers). Francis V. Chisari collaborates with scholars based in United States, Italy and Germany. Francis V. Chisari's co-authors include Luca G. Guidotti, Stefan Wieland, Carlo Ferrari, Robert H. Purcell, Robert Thimme, Masanori Isogawa, Sharookh B. Kapadia, Pablo Gastaminza, Barbara Rehermann and Josan Chung and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Francis V. Chisari

301 papers receiving 43.3k citations

Hit Papers

Robust hepatitis C virus infection in vitro 1989 2026 2001 2013 2005 1995 1999 2002 2001 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Robust hepatitis C virus infection in vitro
    2005 1.4k citations Jin Zhong, Pablo Gastaminza et al. Proceedings of the National Academy of Sciences profile →
  2. Hepatitis B Virus Immunopathogenesis
    1995 1.3k citations Francis V. Chisari, Carlo Ferrari profile →
  3. Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
    1999 980 citations Luca G. Guidotti, Josan Chung et al. profile →
  4. Genomic analysis of the host response to hepatitis C virus infection
    2002 956 citations Robert Thimme, Stefan Wieland et al. Proceedings of the National Academy of Sciences profile →
  5. Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection
    2001 933 citations Robert Thimme, Francis V. Chisari et al. The Journal of Experimental Medicine profile →
  6. Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
    1996 907 citations Luca G. Guidotti, Francis V. Chisari et al. profile →
  7. Noncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse
    2001 816 citations Luca G. Guidotti, Francis V. Chisari profile →
  8. CD8 + T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection
    2002 757 citations Robert Thimme, Stefan Wieland et al. Journal of Virology profile →
  9. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
    1994 724 citations Alessandro Sette, P Fowler et al. The Journal of Immunology profile →
  10. Interferon modulation of cellular microRNAs as an antiviral mechanism
    2007 712 citations Guofeng Cheng, Stefan Wieland et al. profile →
  11. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response
    1996 659 citations Carlo Ferrari, C Pasquinelli et al. profile →
  12. IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
    2006 612 citations Luca G. Guidotti, Francis V. Chisari profile →
  13. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
    1989 564 citations Francis V. Chisari, C Pasquinelli et al. profile →
  14. High-level hepatitis B virus replication in transgenic mice
    1995 534 citations Luca G. Guidotti, Francis V. Chisari et al. Journal of Virology profile →
  15. Genomic analysis of the host response to hepatitis B virus infection
    2004 516 citations Stefan Wieland, Robert Thimme et al. Proceedings of the National Academy of Sciences profile →
  16. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease
    2002 512 citations Robert Thimme, Stefan Wieland et al. Proceedings of the National Academy of Sciences profile →
  17. Short-Range Exosomal Transfer of Viral RNA from Infected Cells to Plasmacytoid Dendritic Cells Triggers Innate Immunity
    2012 377 citations Bryan Boyd, Josan Chung et al. profile →
  18. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
    1995 283 citations Andreas Cerny, John G. McHutchison et al. Journal of Clinical Investigation profile →
  19. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
    1996 261 citations John G. McHutchison, Michael Houghton et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francis V. Chisari United States 117 29.8k 25.5k 14.8k 7.8k 5.3k 301 44.4k
Charles M. Rice United States 140 27.4k 0.9× 30.6k 1.2× 13.1k 0.9× 16.8k 2.2× 16.0k 3.0× 476 67.0k
Michael Houghton United States 82 21.9k 0.7× 27.0k 1.1× 3.9k 0.3× 4.3k 0.5× 2.8k 0.5× 248 32.7k
Stanley M. Lemon United States 86 11.2k 0.4× 15.4k 0.6× 4.8k 0.3× 7.4k 0.9× 6.5k 1.2× 381 26.7k
Paul Klenerman United Kingdom 88 10.8k 0.4× 7.6k 0.3× 14.4k 1.0× 3.5k 0.5× 4.4k 0.8× 500 27.7k
Michael Gale United States 94 9.7k 0.3× 7.3k 0.3× 18.3k 1.2× 10.0k 1.3× 8.5k 1.6× 331 33.2k
Takaji Wakita Japan 78 13.6k 0.5× 15.4k 0.6× 2.7k 0.2× 5.4k 0.7× 4.7k 0.9× 462 24.4k
Kunitada Shimotohno Japan 74 8.5k 0.3× 10.4k 0.4× 4.7k 0.3× 7.8k 1.0× 1.9k 0.4× 355 21.8k
Jane A. McKeating United Kingdom 73 11.2k 0.4× 12.2k 0.5× 3.9k 0.3× 3.6k 0.5× 3.4k 0.6× 232 21.0k
Hubert E. Blum Germany 78 9.9k 0.3× 11.1k 0.4× 3.1k 0.2× 3.8k 0.5× 1.7k 0.3× 339 19.3k
Michael G. Katze United States 91 9.7k 0.3× 3.2k 0.1× 10.2k 0.7× 10.9k 1.4× 6.8k 1.3× 300 27.8k

Countries citing papers authored by Francis V. Chisari

Since Specialization
Citations

This map shows the geographic impact of Francis V. Chisari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis V. Chisari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis V. Chisari more than expected).

Fields of papers citing papers by Francis V. Chisari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis V. Chisari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis V. Chisari. The network helps show where Francis V. Chisari may publish in the future.

Co-authorship network of co-authors of Francis V. Chisari

This figure shows the co-authorship network connecting the top 25 collaborators of Francis V. Chisari. A scholar is included among the top collaborators of Francis V. Chisari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis V. Chisari. Francis V. Chisari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sitia, Giovanni, Roberto Aiolfi, Pietro Di Lucia, et al.. (2012). Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proceedings of the National Academy of Sciences. 109(32). E2165–72. 260 indexed citations
2.
Asabe, Shinichi, Stefan Wieland, Pratip K. Chattopadhyay, et al.. (2009). The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection. Journal of Virology. 83(19). 9652–9662. 244 indexed citations
3.
Iannacone, Matteo, Giovanni Sitia, Masanori Isogawa, et al.. (2008). Platelets prevent IFN-α/β-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus. Proceedings of the National Academy of Sciences. 105(2). 629–634. 101 indexed citations
4.
Cheng, Guofeng, Jin Zhong, Josan Chung, & Francis V. Chisari. (2007). Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proceedings of the National Academy of Sciences. 104(21). 9035–9040. 132 indexed citations
5.
Isogawa, Masanori, et al.. (2007). PD-1:PD-L1 Interactions Contribute to the Functional Suppression of Virus-Specific CD8+ T Lymphocytes in the Liver. The Journal of Immunology. 178(5). 2714–2720. 204 indexed citations
6.
Zhong, Jin, Pablo Gastaminza, Josan Chung, et al.. (2006). Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost. Journal of Virology. 80(22). 11082–11093. 211 indexed citations
7.
Uprichard, Susan L., Bryan Boyd, Alana Althage, & Francis V. Chisari. (2005). Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proceedings of the National Academy of Sciences. 102(3). 773–778. 156 indexed citations
8.
Zhong, Jin, Pablo Gastaminza, Guofeng Cheng, et al.. (2005). Robust hepatitis C virus infection in vitro. Proceedings of the National Academy of Sciences. 102(26). 9294–9299. 1430 indexed citations breakdown →
9.
Kapadia, Sharookh B. & Francis V. Chisari. (2005). Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proceedings of the National Academy of Sciences. 102(7). 2561–2566. 417 indexed citations
10.
Thimme, Robert, Stefan Wieland, John Ghrayeb, et al.. (2002). CD8 + T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection. Journal of Virology. 77(1). 68–76. 757 indexed citations breakdown →
11.
Sette, Alessandro, Carla Oseroff, John Sidney, et al.. (2001). Overcoming T Cell Tolerance to the Hepatitis B Virus Surface Antigen in Hepatitis B Virus-Transgenic Mice. The Journal of Immunology. 166(2). 1389–1397. 65 indexed citations
12.
Kakimi, Kazuhiro, Thomas E. Lane, Francis V. Chisari, & Luca G. Guidotti. (2001). Cutting Edge: Inhibition of Hepatitis B Virus Replication by Activated NK T Cells Does Not Require Inflammatory Cell Recruitment to the Liver. The Journal of Immunology. 167(12). 6701–6705. 80 indexed citations
13.
Schirmbeck, Reinhold, Xin Zheng, Michael Roggendorf, et al.. (2001). Targeting Murine Immune Responses to Selected T Cell- or Antibody-Defined Determinants of the Hepatitis B Surface Antigen by Plasmid DNA Vaccines Encoding Chimeric Antigen. The Journal of Immunology. 166(2). 1405–1413. 30 indexed citations
14.
McKinney, Denise M., Ann L. Erickson, Christopher M. Walker, et al.. (2000). Identification of Five Different Patr Class I Molecules That Bind HLA Supertype Peptides and Definition of Their Peptide Binding Motifs. The Journal of Immunology. 165(8). 4414–4422. 24 indexed citations
15.
Voehringer, David, Claudine Blaser, Andrea Busse Grawitz, et al.. (2000). Break of T Cell Ignorance to a Viral Antigen in the Liver Induces Hepatitis. The Journal of Immunology. 165(5). 2415–2422. 68 indexed citations
16.
Cerny, Andreas, John G. McHutchison, C Pasquinelli, et al.. (1995). Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.. Journal of Clinical Investigation. 95(2). 521–530. 283 indexed citations breakdown →
17.
Bertoletti, Antonio, Antonio Costanzo, Francis V. Chisari, et al.. (1994). Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.. The Journal of Experimental Medicine. 180(3). 933–943. 187 indexed citations
18.
Teeter, Larry D., et al.. (1990). Overexpression of the Multidrug Resistance Gene mdr3 in Spontaneous and Chemically Induced Mouse Hepatocellular Carcinomas. Molecular and Cellular Biology. 10(11). 5728–5735. 8 indexed citations
19.
Chisari, Francis V.. (1984). Advances in hepatitis research. Masson eBooks. 40 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles M. Rice Breakdown of academic impact, for papers by Michael Houghton Breakdown of academic impact, for papers by Stanley M. Lemon Breakdown of academic impact, for papers by Paul Klenerman Breakdown of academic impact, for papers by Michael Gale Breakdown of academic impact, for papers by Takaji Wakita Breakdown of academic impact, for papers by Kunitada Shimotohno Breakdown of academic impact, for papers by Jane A. McKeating Breakdown of academic impact, for papers by Hubert E. Blum Breakdown of academic impact, for papers by Michael G. Katze
Rankless by CCL
2026